Enzo Grasso
Enzo Grasso has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Maloberti
Cardiology Department De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
1 shared publication - Alessandro Verde
CardioThoracic and Vascular Department, "A. De Gasperis" Niguarda Ca' Granda Hospital, Milan, Italy
1 shared publication - Andrea Sonaglioni
Cardiology, MultiMedica, Milan, Italy, Italy
1 shared publication - Antonella Caminati
Semi-Intensive Care Unit, Division of Pneumology, IRCCS MultiMedica, 20123 Milan, Italy
1 shared publication - Antonia Alberti
Territorial Cardiology “A.De Gasperis” Cardio Center, ASST GOM Niguarda Ca’ Granda, 20162 Milan, Italy
1 shared publication - Caterina Santolamazza
Dipartimento Cardio-Toraco-Vascolare, Ospedale Cà Granda-A.O. Niguarda, 20162 Milan, Italy
1 shared publication
Latest Publications
- 1 May 2023
- Published by Edizioni Minerva Medica in Minerva Medica
- Vol. 114 (5) , 608-619
Comparison of clinical scoring to predict mortality risk in mild-to-moderate idiopathic pulmonary fibrosis
Article: Comparison of clinical scoring to predict mortality risk in mild-to-moderate idiopathic pulmonary fibrosis - Minerva Medica 2023 May 19 - Minerva Medica - Journals
- 1 May 2023
- Published by Edizioni Minerva Medica in Minerva Medica
- Vol. 114 (5) , 608-619
Comparison of clinical scoring to predict mortality risk in mild-to-moderate idiopathic pulmonary fibrosis
Article: Comparison of clinical scoring to predict mortality risk in mild-to-moderate idiopathic pulmonary fibrosis - Minerva Medica 2023 May 19 - Minerva Medica - Journals
- Open Access
- 28 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5590
Heart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity
The most common arrhythmia associated with COronaVIrus-related Disease (COVID) infection is sinus tachycardia. It is not known if high Heart Rate (HR) in COVID is simply a marker of higher systemic response to sepsis or if its persistence could be related to a long-term autonomic dysfunction. The aim of our work is to assess the prevalence of elevated HR at discharge in patients hospitalized for COVID-19 and to evaluate the variables associated with it. We enrolled 697 cases of SARS-CoV2 infection admitted in our hospital after February 21 and discharged within 23 July 2020. We collected data on clinical history, vital signs, laboratory tests and pharmacological treatment. Severe disease was defined as the need for Intensive Care Unit (ICU) admission and/or mechanical ventilation. Median age was 59 years (first-third quartile 49, 74), and male was the prevalent gender (60.1%). 84.6% of the subjects showed a SARS-CoV-2 related pneumonia, and 13.2% resulted in a severe disease. Mean HR at admission was 90 ± 18 bpm with a mean decrease of 10 bpm to discharge. Only 5.5% of subjects presented HR > 100 bpm at discharge. Significant predictors of discharge HR at multiple linear model were admission HR (mean increase = β = 0.17 per bpm, 95% CI 0.11; 0.22, p < 0.001), haemoglobin (β = −0.64 per g/dL, 95% CI −1.19; −0.09, p = 0.023) and severe disease (β = 8.42, 95% CI 5.39; 11.45, p < 0.001). High HR at discharge in COVID-19 patients is not such a frequent consequence, but when it occurs it seems strongly related to a severe course of the disease.
- 28 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5590
Open AccessHeart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity
The most common arrhythmia associated with COronaVIrus-related Disease (COVID) infection is sinus tachycardia. It is not known if high Heart Rate (HR) in COVID is simply a marker of higher systemic response to sepsis or if its persistence could be related to a long-term autonomic dysfunction. The aim of our work is to assess the prevalence of elevated HR at discharge in patients hospitalized for COVID-19 and to evaluate the variables associated with it. We enrolled 697 cases of SARS-CoV2 infection admitted in our hospital after February 21 and discharged within 23 July 2020. We collected data on clinical history, vital signs, laboratory tests and pharmacological treatment. Severe disease was defined as the need for Intensive Care Unit (ICU) admission and/or mechanical ventilation. Median age was 59 years (first-third quartile 49, 74), and male was the prevalent gender (60.1%). 84.6% of the subjects showed a SARS-CoV-2 related pneumonia, and 13.2% resulted in a severe disease. Mean HR at admission was 90 ± 18 bpm with a mean decrease of 10 bpm to discharge. Only 5.5% of subjects presented HR > 100 bpm at discharge. Significant predictors of discharge HR at multiple linear model were admission HR (mean increase = β = 0.17 per bpm, 95% CI 0.11; 0.22, p < 0.001), haemoglobin (β = −0.64 per g/dL, 95% CI −1.19; −0.09, p = 0.023) and severe disease (β = 8.42, 95% CI 5.39; 11.45, p < 0.001). High HR at discharge in COVID-19 patients is not such a frequent consequence, but when it occurs it seems strongly related to a severe course of the disease.
- 1 June 2016
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 115, 49
Immunoregulation of the decidualization program
- 1 June 2016
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 115, 49
Immunoregulation of the decidualization program